ArticleJournal of thoracic disease2025
Association of stress hyperglycemia ratio with clinical outcomes in patients with chronic obstructive pulmonary disease and type 2 diabetes mellitus in intensive care units: a retrospective study.
Article in Journal of thoracic disease, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- The Joint Effect of Stress Hyperglycemia Ratio and Inflammatory Burden Exacerbates Mortality Risk and Prolongs ICU Stay in Sepsis: A Combined Analysis.Infection and drug resistance · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Co-morbidity of chronic obstructive pulmonary disease (COPD) and type 2 diabetes mellitus (T2DM) corresponds to increasing severity and adverse clinical outcomes. This study intends to investigate the association of stress hyperglycemia ratio (SHR) with adverse outcomes in critically ill patients with COPD and T2DM. Methods: Critically ill patients diagnosed with COPD and T2DM from 2008 to 2019 were retrospectively included from the Medical Information Mart for Intensive Care IV (MIMIC-IV; version 2.2). They were assigned into three groups based on SHR tertiles, and all-cause in-hospital mortality (ACIHM) and length of intensive care unit (ICU) stay (LOIS) were the primary and secondary outcomes, respectively. The association of SHR with adverse outcomes was explored by Logistic regression, generalized linear regression, and restricted cubic spline (RCS) curve analyses, and its robustness was verified by subgroup analyses. Results: Totally 1,781 patients with COPD and T2DM were included. Logistic regression analyses revealed that after adjusting for all confounders, the risk of ACIHM increased by 51% in T3 compared with T1 [odds ratio (OR) =1.51; 95% confidence interval (CI): 1.06-2.16]. RCS curve analyses showed a statistically significant linear association between SHR and ACIHM (P Conclusions: A high SHR is associated with an increase in ACIHM and LOIS in critically ill patients with COPD and T2DM. Assessment of SHR may contribute to better risk stratification and prognostic prediction for such patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.